U
BIOA

UBS’s BioAmber Inc. BIOA Stock Holding History

UBS’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-442
Closed -$3K – 10929
2013
Q2 		$3K Buy
+442
New +$3.29K ﹤0.01% 9683

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

UBS's BIOA Position: Q3 2013 in Review

UBS sold out of BioAmber Inc. (BIOA) in Q3 2013, closing a stake of 442 shares — an estimated $3K sold.

UBS first reported a position in BIOA in Q2 2013 and held it in 1 quarter. The position peaked at $3K in Q2 2013. 15 funds tracked by Wall St. Rank hold BIOA as of Q3 2013.

  • UBS reported no remaining BioAmber Inc. position as of Q3 2013 after selling out during the quarter.
  • UBS sold 442 BioAmber Inc. shares in Q3 2013, an estimated $3K.
  • UBS first reported a position in BioAmber Inc. in Q2 2013 and held it in 1 quarter.
  • UBS's BioAmber Inc. position peaked at $3K in Q2 2013.
  • 15 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2013.

Based on UBS's 13F filing for Q3 2013, filed 13 Nov 2013.